<?xml version="1.0" encoding="UTF-8"?>
<p>The integration of genetics and single cell transcriptomics from human brain is beginning to reveal the biological context of risk variants. In PD, these data show a clear enrichment of genes from risk loci in dopaminergic neurons as well as in oligodendroglia [
 <xref rid="ref007" ref-type="bibr">7</xref>]; while this would suggest that modeling the biological effects of risk variants should be prioritized in these cell types, an important prerequisite is an understanding of the biological landscape of such cells, so that we can understand the biological fidelity of our models.
</p>
